Adaptimmune Therapeutics Plc (ADAPY)
0.026
0.00 (0.00%)
USD |
OTCM |
Feb 10, 16:00
Adaptimmune Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Silence Therapeutics Plc | 3.061 |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 0.4458 |
| Autolus Therapeutics Plc | 1.899 |
Price to Book Value Related Metrics
| PS Ratio | 0.1022 |
| PEG Ratio | -0.0004 |
| Price | 0.026 |
| Earnings Yield | -2.54K% |
| Market Cap | 6.891M |
| PEGY Ratio | -0.0004 |